Patient P-01435
Therapy response
Improving
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S03
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-24
- Inflammatory activity-12
- Nutritional resilience+10
- Toxicity+6
- Treatment adherence+3
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion15.2/100
worsening · +2.6 vs previous 14 d
Toxicity
Blood20.2/100
worsening · +6.8 vs previous 14 d
Sleep quality
Wearable55.6/100
stable · +0.6 vs previous 14 d
Energy level
Daily log7.2/10
stable · +0.0 vs previous 14 d
Stress level
Daily log4.3/10
worsening · +0.4 vs previous 14 d
Steps
Wearable4,441
worsening · -621 vs previous 14 d
Adherence
Companion97.1 %
stable · +2.3 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 90 from the failing basin, 5 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Alcohol+1.9no signal · 25%
- Histamine load-1.3no signal · 16%
- Spicy / capsaicin-1no signal · 15%
- Simple carbohydrates-0.7no signal · 15%
- Insoluble fibre+0.6no signal · 15%
- Dietary fat load-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.9 · butyrate capacity 62/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 60 ms
- Sleep
- 7.5 h
- Steps
- 3,292
- Resting HR
- 60 bpm
Daily log: GI score 15, nutritional resilience 65, adherence 97.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01766 | 45% | S05 | AD-05 | no change | 90 |
| P-01804 | 29% | S19 | AD-05 | improved | 61 |
| P-01541 | 26% | S09 | AD-05 | no change | 43 |
| P-01329 | 49% | S08 | BR-03 | improved | 79 |
| P-01677 | 42% | S05 | BR-03 | no change | 86 |
| P-01495 | 37% | S07 | BR-03 | improved | 85 |
| P-01689 | 27% | S13 | BR-03 | no change | 50 |
| P-01654 | 40% | S08 | CR-01 | improved | 85 |
| P-01430 | 27% | S05 | CR-01 | improved | 54 |
| P-01479 | 38% | S15 | DT-01 | improved | 84 |
| P-01855 | 35% | S04 | DT-01 | improved | 73 |
| P-01767 | 33% | S14 | DT-01 | no change | 63 |